Mr. Oren Shuster reports

IM CANNABIS ANNOUNCES THE APPOINTMENT OF URI BIRENBERG AS CHIEF FINANCIAL OFFICER

IM Cannabis Corp. has appointed Uri Birenberg as its chief financial officer, effective Oct. 10, 2023. This appointment strengthens IM Cannabis's financial leadership and strategic direction for achieving sustainable profitability.

"We're delighted to welcome Uri as our new chief financial officer at IMC. His impressive track record and extensive experience with large-scale international organizations, as well as with start-ups, make him an outstanding candidate for this important role in our company," said Oren Shuster, chief executive officer of IM Cannabis. "Uri will play a critical role in helping us achieve our financial and strategic goals and further strengthen the partnership with our investors. With his clear focus on sustainable growth and passion for innovative solutions, I'm confident he will make significant contributions to support our continued success."

"I am very excited to be joining IMC at this important stage of the company's development," said Mr. Birenberg. "I look forward to working with Oren and the team in delivering IMC's strategic priority of achieving sustainable profitability."

Mr. Birenberg is a senior financial executive, who brings over two decades of experience of financial planning and analysis. Prior to joining IM Cannabis, MR. Birenberg served as CFO of Hygear Ltd., a start-up in the health care fitness technology industry. In addition to managing the financial and legal activities of the company, along with the strategic financial planning, he played an essential role in the fundraising in preparation for its IPO (initial public offering).

Mr. Birenberg follows Itay Vago, who will be leaving the position after presenting the company's Q3 2023 results in November, 2023. During the next weeks, Mr. Birenberg and Mr. Vago will be working together closely to assure a smooth transition process.

About IM Cannabis Corp.

IM Cannabis is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest-value markets, Israel and Germany. The company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IM Cannabis ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The company also operates medical cannabis retail pharmacies, on-line platforms, distribution centres and logistical hubs in Israel that enable the safe delivery and quality control of IM Cannabis products throughout the entire value chain. In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the company also actively operated in Canada through Trichome Financial Corp. and its wholly owned subsidiaries, where it cultivated, processed, packaged and sold premium and ultrapremium cannabis at its own facilities under the Wagners and Highland Grow brands for the adult-use market in Canada. The company has exited operations in Canada and considers these operations discontinued.

We seek Safe Harbor.